Related references
Note: Only part of the references are listed.Interpretation of early imaging after concurrent radiotherapy and temozolomide for glioblastoma
S. Jefferies et al.
CLINICAL ONCOLOGY (2007)
Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma
Marc C. Chamberlain et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma:: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO)
A. A. Brandes et al.
BRITISH JOURNAL OF CANCER (2006)
Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: A prospective GICNO study
Alba A. Brandes et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas
Isabelle Catalaa et al.
NMR IN BIOMEDICINE (2006)
Radiotherapy and temozolomide for newly diagnosed glioblastoma: Recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial
RO Mirimanoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression
MCY de Wit et al.
NEUROLOGY (2004)
Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy
HP Schlemmer et al.
NEURORADIOLOGY (2002)
Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment
AJ Kumar et al.
RADIOLOGY (2000)
Share Paper
